NIVA YACOV, PHD

Dr. Niva Yacov, previously served as the Business Development Manager and Head of Pre-Clinical Studies at VBL Therapeutics (Nasdaq: VBLT). She brings over 24 years of industry experience, encompassing research and drug development, business development, strategic planning, intellectual property, as well as clinical and regulatory operations.

Dr. Yacov has scientific expertise in immunology and cancer and has vast experience in the development of novel technologies and drug candidates. She received her Doctor of Philosophy degree from Tel Aviv University, Israel, and holds CRA, CTA, and CRC certifications from the GCP Training Center and the Technion, Haifa, Israel.